Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Inspiremd › Director received an award of 44K NSPR derivative securities Insider trades
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Sep 18, 2026
Reporting period Not applicable
Filed with the SEC Sep 23, 2026 Director Indirect holding Grant / award
Context Classification grant award
Derivative acquisition at no reported price
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
0001493152-26-043910
Filed / recorded Sep 23, 2026, 8:05 PM UTC
Added to OQRO Oct 8, 2026, 2:27 AM UTC
Data quality Verified: identifiers matched exactly
Reporting person Paul Stuka
Security Series J Warrant (right to buy)
Table Derivative (Table II)
Transaction date Sep 18, 2026
Acquired / disposed Acquired (A)
Ownership form Indirect — See Footnote
Footnotes from the filing See Exhibit 99.1; Note 1 See Exhibit 99.1; Note 4 See Exhibit 99.1; Note 3
Around the same time Insider filing
Traded Sep 18 · filed 5 days later
Not classified as an open-market trade.
Insider filing
Traded Sep 18 · filed 5 days later
Not classified as an open-market trade.
Insider filing
Traded Sep 18 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Jul 17, 2026 Company filing · Form 8-K · Listing notice Received a notice from its stock exchange “On July 17, 2026, InspireMD, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of…” Jul 23, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On July 23, 2026, InspireMD, Inc. (the “Company”) provided notice to Shane Gleason, the Company’s Chief Commercial Officer, that his position has been eliminated.” Aug 17, 2026 Company filing · Form 8-K · Results Reported its results What came next Sep 21, 2026 Company filing · Form 8-K · Material agreement, Unregistered shares Signed an important agreement, and sold new shares without registering them (and 1 more item) Nov 12, 2026 Company filing · Form 8-K · Results, Other news Reported its results, and reported other company news Nov 13, 2026 Insider · 5 people Insiders: 5 purchases (~$455K) Nov 16, 2026